Senseonics Holdings, Inc. is a cutting-edge medical technology firm headquartered in Germantown, Maryland, specializing in the development of innovative continuous glucose monitoring (CGM) systems for diabetes management. The company's proprietary CGM solutions provide real-time glucose data and actionable insights, significantly enhancing patient outcomes and quality of life for individuals with diabetes. With its products currently available in the United States, Europe, the Middle East, and Africa, Senseonics is strategically positioned to capitalize on the increasing global demand for advanced diabetes management tools, contributing to its growth in an evolving healthcare market.
Click "Analyze" to generate stock analysis
SENS Price Trend and Signals
SENS Option Volumes & Open Interests (aggregated)
SENS Put Call Ratios and IV (aggregated)
SENS Financials
2025-10-20Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-20Somewhat Bullishprice_signal
Yearly high detected.
2025-10-20Bullishprice_signal
Large price change detected: 1965.85%.
2025-10-17Somewhat Bearishprice_signal
Half-yearly low detected.
2025-10-10Bearishmacd_signal
Dead cross below zero detected.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-06Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.